Securities code: Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) securities abbreviation: Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) Announcement No.: 2022032 bond Code: 110076 bond abbreviation: Huahai convertible bond
Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) directors’ progress announcement on share reduction
The board of directors, all directors and relevant shareholders of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important content tips:
Basic information of directors’ shareholding: before the implementation of this shareholding reduction plan, Mr. Du Jun, a director of Zhejiang Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) Co., Ltd. (hereinafter referred to as “the company”), held 1930307 shares of the company, accounting for 0.1294% of the total share capital of the company. As of the disclosure date of this announcement, Mr. Du Jun holds 1760307 shares of the company, accounting for 0.1180% of the total share capital of the company.
Progress of the reduction plan: as of the disclosure date of this announcement, Mr. Du Jun’s reduction plan has been more than half, and he has reduced 170000 shares of the company in total.
1、 Basic information of the reducing entity before the reduction
Number of shares held
Shareholder name shareholder identity shareholding proportion current shareholding source (share)
Du Jun, director, supervisor, 19303070.1294% obtained by other means:
1930307 senior management shares
Note: Mr. Du Jun, the director of the company, currently holds shares mainly from the acquisition of equity incentive of the company and the acquisition of shares obtained by the company through conversion over the years.
The above reduction subjects have no concerted action.
2、 Implementation progress of share reduction plan
(I) the directors disclose the implementation progress of the reduction plan for the following reasons:
The reduction time is more than half
Reduction price
Number of shareholders’ holdings reduction total amount of holdings reduction in Beagle interval current number of shares current holdings reduction method during current holdings reduction
Weighing (share) example (yuan / (yuan) quantity (share) proportion (share)
Du Jun 1700000.0114% 2022 / 1 / 10 centralized bidding 24.00424 Shenzhen China Bicycle Company (Holdings) Limited(000017) 603070.1180% ~ 2022 / 4 / 10 transaction -27.00
(II) whether the reduction is consistent with the plans and commitments previously disclosed by major shareholders or directors, supervisors and senior executives
√ yes □ no
(III) whether the listed company has disclosed major issues such as high transfer or planning merger and reorganization within the reduction time period
□ yes √ no
(IV) impact of this reduction on the company
The share reduction plan of the listed company complies with the Listing Rules of Shanghai Stock Exchange
The relevant provisions of relevant laws, regulations and normative documents, such as several provisions on the reduction of shares by high-tech enterprises, will not be implemented after its implementation
It will lead to changes in the company’s control and will not have an impact on the company’s governance structure and going concern.
(V) other matters required by the exchange
nothing
3、 Relevant risk tips (I) the reduction plan is independently decided by Mr. Du Jun, the director of the company, according to his personal capital needs. During the reduction period, the reduction subject will choose whether to implement the share reduction plan according to the market conditions, the company’s share price and other factors, which is uncertain. Mr. Du Jun will implement the reduction plan in strict accordance with the provisions of relevant laws, regulations and normative documents such as the securities law, the stock listing rules of Shanghai Stock Exchange, several provisions on the reduction of shares by shareholders, directors, supervisors and senior executives of listed companies, The company will fulfill the obligation of information disclosure in a timely manner in strict accordance with relevant regulations. (II) whether the implementation of the reduction plan will lead to the risk of change of control of the listed company □ yes √ no is hereby announced.
Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) board of directors April 10, 2022
